Anti-aquaporin 4 antibody-positive acute disseminated encephalomyelitis

Brain and Development

Volumn 37, Issue 3, 2015, Pages 339-343

  Okumura, Akihisa ^a,b   Nakazawa, Mika ^a   Igarashi, Ayuko ^a   Abe, Shinpei ^a   Ikeno, Mitsuru ^a   Nakahara, Eri ^a   Yamashiro, Yuichiro ^c   Shimizu, Toshiaki ^a   Takahashi, Toshiyuki ^d  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute disseminated encephalomyelitis; Anti aquaporin 4 antibody; Optic neuritis; Steroids; Vaccination

Indexed keywords

ACICLOVIR; AQUAPORIN 4 ANTIBODY; INFLUENZA VACCINE; MANNITOL; METHYLPREDNISOLONE; MYELIN BASIC PROTEIN; PREDNISOLONE; ANTIINFLAMMATORY AGENT; AQUAPORIN 4; AUTOANTIBODY;

2009 H1N1 INFLUENZA; ACUTE DISSEMINATED ENCEPHALOMYELITIS; ANTIBODY BLOOD LEVEL; ARTICLE; BRAIN DAMAGE; BRAIN DISEASE; CASE REPORT; CELL ASSAY; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL FEATURE; DISEASE COURSE; DISEASE DURATION; ELECTROENCEPHALOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL DISCHARGE; HUMAN; HYPERREFLEXIA; INFLUENZA A (H3N2); INFLUENZA VACCINATION; MENINGITIS; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE LESION; OPTIC NEURITIS; PHYSICAL EXAMINATION; PRESCHOOL CHILD; RETROBULBAR OPTIC NEUROPATHY; SERUM; SOMNOLENCE; STEROID THERAPY; TREATMENT DURATION; TREATMENT OUTCOME; WHITE MATTER LESION; BLOOD; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; IMMUNOLOGY;

ANTI-INFLAMMATORY AGENTS; AQUAPORIN 4; AUTOANTIBODIES; CHILD, PRESCHOOL; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; HUMANS; PREDNISOLONE;

EID: 84922768429     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2014.04.013     Document Type: Article

References (18)

1. Trebst C., Jarius S., Berthele A., Paul F., Schippling S., Wildemann B., et al. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol 2014, 261:1-16.
2. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112.
3. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202:473-477.
4. Jarius S., Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 2010, 6:383-392.
5. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.
6. Takahashi T., Fujihara K., Nakashima I., Misu T., Miyazawa I., Nakamura M., et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007, 130:1235-1243.
7. Krupp L.B., Tardieu M., Amato M.P., Banwell B., Chitnis T., Dale R.C., et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013, 19:1261-1267.
8. McKeon A., Lennon V.A., Lotze T., Tenenbaum S., Ness J.M., Rensel M., et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008, 71:93-100.
9. Hino-Fukuyo N., Takahashi T., Haginoya K., Uematsu M., Tsuchiya S., Fujihara K. Clinical features of Japanese pediatric patients with anti-aquaporin 4 antibody (In Japanese). No To Hattatsu 2011, 43:359-365.
10. Long Y., Qiu W., Hu X., Peng F., Lu Z., Wang Y., et al. Anti-aquaporin-4 antibody in Chinese patients with central nervous system inflammatory demyelinating disorders. Clin Neurol Neurosurg 2012, 114:1131-1134.
11. Saiki S., Ueno Y., Moritani T., Sato T., Sekine T., Kawajiri S., et al. Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica. J Neurol Sci 2009, 284:217-219.
12. Lotze T.E., Northrop J.L., Hutton G.J., Ross B., Schiffman J.S., Hunter J.V. Spectrum of pediatric neuromyelitis optica. Pediatrics 2008, 122:e1039-e1047.
13. Leake J.A., Albani S., Kao A.S., Senac M.O., Billman G.F., Nespeca M.P., et al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 2004, 23:756-764.
14. Tenembaum S., Chamoles N., Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 2002, 59:1224-1231.
15. Lapphra K., Huh L., Scheifele D.W. Adverse neurologic reactions after both doses of pandemic H1N1 influenza vaccine with optic neuritis and demyelination. Pediatr Infect Dis J 2011, 30:84-86.
16. Fujii K., Suyama M., Chiba K., Okunushi T., Oikawa J., Kohno Y. Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccine. Pediatr. Int. 2012, 54:539-541.
17. Marin S.E., Callen D.J. The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: an update post application of the 2007 consensus criteria. Neuroimaging Clin N Am 2013, 23:245-266.
18. Collongues N., Marignier R., Zéphir H., Papeix C., Fontaine B., Blanc F., et al. Long-term follow-up of neuromyelitis optica with a pediatric onset. Neurology 2010, 75:1084-1088.